GeneDx Holdings Corp. (WGS) insider trading

By person

27 insiders · 457 transactions

15.9×

Katherine Stueland holds 15.9 times base salary in stock. $11.43M of shares against $715.87K in salary for 2025.

Salary from the company's own proxy. The shares are what Katherine Stueland last reported holding, valued at $99.00, the price Class A Common Stock was last bought or sold at on the open market here, on 16 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Keith A. Meister

Director

$128.39M (35)

$3.85M (2)

+$124.54M

4,808,275

16.12%

$476.00M

—

Eli Casdin

Director

$75.75M (3)

—

+$75.75M

30,303,586

—

$3.00B

—

School Of Medicine At Mount Sinai Icahn

10% owner

$35.00M (2)

$75.33M (3)

−$40.33M

2,719,692

9.12%

$269.24M

—

Katherine Stueland

Chief Executive Officer

$100.00K (1)

$39.36M (123) scheduled

−$39.26M

115,476

0.3872%

$11.43M

−49.3%

Opko Health, Inc. entity

10% owner

$5.00M (1)

$29.70M (19)

−$24.70M

2,646,972

8.88%

$262.04M

—

Casdin Capital, LLC entity

Director

$41.12M (14)

$60.45M (1)

−$19.33M

7,214,328

24.19%

$714.18M

+16.9%

Kevin Feeley

Chief Financial Officer

—

$14.48M (122) scheduled

−$14.48M

44,945

0.1507%

$4.45M

—

Blackstone Tactical Opportunities Associates III - NQ L.P. entity

10% owner

$10.00M (3)

—

+$10.00M

162,309

0.5442%

$16.07M

—

BTO Sema4 Holdings L.P. entity

10% owner

$10.00M (3)

—

+$10.00M

162,309

0.5442%

$16.07M

—

Jason Ryan

Director

$161.37K (2)

$8.33M (16)

−$8.17M

118,764

0.3982%

$11.76M

+282.0%

Joshua Ruch

Director

—

$6.09M (15)

−$6.09M

153,382

0.5143%

$15.18M

—

Bryan Dechairo

Chief Operating Officer

—

$850.56K (12) scheduled

−$850.56K

0.0000%

$0.00

—

Isaac Ro

Former CFO

—

$727.24K (8) scheduled

−$727.24K

244,041

0.8183%

$24.16M

—

Kareem Saad

Chief Transformation Officer

—

$259.50K (27)

−$259.50K

29,517

0.0990%

$2.92M

—

Eric Schadt

President & Chief R&D Officer

$192.48K (1)

$412.26K (3) scheduled

−$219.78K

243,380

0.8161%

$24.09M

—

Richard C Pfenniger Jr

Director

$69.91K (3)

—

+$69.91K

45,082

0.1512%

$4.46M

—

Karen Ann White

Chief People Officer

—

$57.27K (17)

−$57.27K

4,761

0.0160%

$471.32K

—

Shawn Assad

Former CAO

—

$52.10K (5)

−$52.10K

43,040

0.1443%

$4.26M

+4,303,900%

James Coffin

President and COO

—

$43.37K (1) scheduled

−$43.37K

22,903

0.0768%

$2.27M

—

Anthony Prentice

Former Chief Product Officer

—

$27.44K (5)

−$27.44K

12,102

0.0406%

$1.20M

—

Daniel Emmett Clark

Former Secretary and GC

—

$19.88K (5)

−$19.88K

312,207

1.05%

$30.91M

+1,445%

Richard Miao

Former Interim CFO

—

$7.06K (2)

−$7.06K

24,867

0.0834%

$2.46M

+43.0%

Rachel E. Sherman

Director

—

58,290

0.1955%

$5.77M

—

Nat Turner

Director

—

37,836

0.1269%

$3.75M

—

Emily M. Leproust

Director

—

24,852

0.0833%

$2.46M

—

Michael J Pellini

Director

—

17,114

0.0574%

$1.69M

—

Thomas Fuchs

Director

—

1,146

0.0038%

$113.45K

—

GeneDx Holdings Corp.

What the insiders did Net buying

By person